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Strengths and limitations of this study
 ► This systematic review protocol follows the Preferred 
Reporting Items for Systematic Reviews and Meta-
Analyses for Protocols guideline.
 ► This protocol prevents the potential for duplication 
and allows for transparency in the research process.
 ► This systematic review will be the first to synthesis 
the prevalence, incidence and patterns of musculo-
skeletal disorders from non-fatal road traffic colli-
sions (RTC) in Africa.
 ► It is hoped that findings from this review will provide 
evidence for policymakers and stakeholders to put 
in place prevention strategies to mitigate the burden 
associated with RTC within this region.
 ► It is likely that there will be some under-reporting in 
the incidence of RTC within Africa.
AbStrACt
Introduction In addition to their high mortality rates, 
road traffic collisions (RTC) are considered a burden 
within those who do survive. In Africa, injuries related 
to RTC have been identified as the 10th most common 
cause of disability-adjusted life years lost for all ages and 
categories. Moreover, non-fatal RTC are the biggest cause 
associated with the burden of musculoskeletal disorders 
(MSD) in Africa. Despite this, the epidemiology of MSD 
related to non-fatal RTC within this region is still unknown.
The objective of this review is to identify and summarise 
available data regarding the prevalence, incidence and 
patterns of MSD resulting from non-fatal RTC in Africa.
Methods and analysis A systematic review of 
observational epidemiological studies will be conducted. 
On October 2019, MEDLINE, Embase, CINAHL Plus, 
PsycINFO, Web of Science, Global Health and African 
Journals OnLine will be searched for literature that is 
in English and published between 1990 and 2018. Two 
reviewers (MY ad TG) will independently screen results 
and extract the data, with a third reviewer (FF) resolving 
any discrepancies through discussion. Additionally, 
two reviewers (MY and TG) will independently assess 
the quality of the eligible studies using the US National 
Institutes of Health National Heart, Lung, and Blood 
Institute Quality Assessment Tool.
Within the eligible studies, data on citation, methods and 
results will be extracted. Extracted data will be analysed 
using a narrative synthesis. Findings will be presented 
in tables, with the main outcomes being prevalence, 
incidence and disease pattern of MSD and determinants 
of non-fatal RTC. The final systematic review will be 
conducted as per the Preferred Reporting Items for 
Systematic Reviews and Meta-Analyses guideline.
Ethics and dissemination As individual patients will 
not be involved in this study, no ethical approval will be 
sought. Findings from this review will be disseminated 
through peer-reviewed journals and relevant conferences.
trial registration number CRD42019139538
bACkground
Over the past few decades, due to the dedi-
cated attention, resources and progress, the 
global burden of disease has shifted from 
communicable diseases to non-commu-
nicable diseases and injuries.1 Surpassing 
tuberculosis and HIV/AIDS, road traffic 
collisions (RTC) are the eighth leading cause 
of death and the number one leading cause 
of death for children and young adults aged 
between 5 and 29 years.2 These rates are at 
their highest in Africa, where there are 26.6 
deaths per 100 000 people; this is substan-
tially high in comparison to Europe where 
the death rate is at its lowest (9.3 deaths per 
100 000 people). Further, the WHO predicts 
that by 2030 injuries from RTC will be the 
seventh leading cause of deaths globally.3
In addition to their high mortality rates, 
RTC are considered a burden within those 
who do survive. They have a significant 
impact on quality of life, clinical and finan-
cial burden, and therefore are a major public 
health problem.4–6 In Africa, injuries related 
to RTC have been identified as the 10th most 
common cause of disability-adjusted life 
years lost for all ages and categories.1 Within 
Africa, non-fatal RTC are the biggest cause 
of burden associated with musculoskeletal 
disorders (MSD); this rate is more than the 
combined burden of the three big non-trau-
matic MSD (low back pain, osteoarthritis and 
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rheumatoid arthritis combined).7 Despite such burden, 
the epidemiology of MSD related to non-fatal RTC within 
this region is still unknown.
There has been previous research evaluating the 
burden of RTC in Africa,8 9 though, there has not yet been 
a systematic review synthesising the epidemiology of MSD 
resulting from non-fatal RTC within Africa. Knowing the 
burden of these disorders is vital as it provides baseline 
data by evaluating what is already known, thus providing 
evidence for policymakers and stakeholders, including 
the WHO and the US Centers for Disease Control,10 11 
who wish to undertake prevention strategies to mitigate 
the burden associated with RTC within Africa.
Aims and objectives
To establish the burden associated with MSD relating 
to non-fatal RTC, we aim to examine the burden of 
MSD-related RTC, with the objective of identifying and 
summarising available data regarding the prevalence, 
incidence and patterns of MSD resulting from non-fatal 
RTC in the different type of road users (pedestrian, 
passenger, driver and cyclists) within Africa.
MEthodS
This systematic review protocol follows the Preferred 
Reporting Items for Systematic Reviews and Meta-Anal-
yses (PRISMA) for Protocols statement.12 Additionally, 
the final systematic review will be conducted as per the 
PRISMA guideline.13
Eligibility criteria
Studies will be included if they were conducted in an 
African country between 1990 and 2018, as within this 
period data capture reporting of non-fatal RTC is antic-
ipated to be of good quality.8 Studies that are of the 
following observational design will also be included: 
cross-sectional, prospective cohort, retrospective cohort 
and case control, and also if they used data from popu-
lation-based or registry-based data systems. Addition-
ally, studies should estimate the number of MSD due 
to non-fatal RTC in pedestrians, passengers, cyclists or 
drivers. Studies will be excluded if they referred to other 
non-road transportation systems, such as water and air, 
and if they were a review, opinion piece, commentary, case 
study and case series. If studies looked at other non-MSD, 
such as neurological injuries or wound infection, they will 
also not be included in the review.
In this review, our case definition is non-fatal injuries, 
including minor injuries with disabilities of short dura-
tion to severe injuries with lifelong disabilities, resulting 
from RTC by various road user types (pedestrians, moto-
rised four-wheeler occupants, motorised two-wheeler 
and three-wheeler users, and cyclists).2 Further, we 
define MSD as soft-tissue injuries or pain within the skel-
etal systems that may be associated with injury affecting 
muscles, bones, ligaments, cartilages and so on.13
Information sources and search strategy
On October 2019, the following electronic databases will 
be searched for relevant literature: MEDLINE, Embase, 
CINAHL Plus, PsycINFO, Web of Science, Global Health 
and African Journals OnLine. With the help of the Univer-
sity librarian, a search strategy will be set in place; the key 
search concepts will be road traffic collision and injuries, 
Africa, observational data design and musculoskeletal 
injuries—see online supplementary file 1 for full search 
terms. Two reviewers (MY and TG) will initially execute 
the search strategy. Search results will be limited to the 
English language.
Study selection
All the abstracts found in the search results will be pooled 
and managed in Zotero referencing software, after that 
duplicates will be removed from this list. Two reviewers 
(MY and TG) will evaluate the titles and abstracts of the 
search results against the prespecified extraction criteria. 
Subsequently, both reviewers will independently screen 
the full articles against the eligibility criteria, any disagree-
ments between the two reviewers will be resolved by the 
third reviewer (FF) through a discussion.
data collection process
Based on the extraction list, two reviewers (MY and TG) 
will independently extract the relevant data into an Excel 
spreadsheet (V.2016, Microsoft). Both reviewers will inde-
pendently cross-check extracted data, if consensus is not 
reached, then a third reviewer (FF) will resolve discrepan-
cies between the two reviewers through discussion.
Once the eligible studies are finalised, the quality of 
studies will be appraised by two reviewers (MY and TG) 
using the US National Institutes of Health National 
Heart, Lung, and Blood Institute Quality Assessment 
Tool (NIH, 2014). This widely used assessment tool 
determines the quality of observational studies. In 
the form of questions, there are 12–14 items within 
the appraisal tool. These include sample size, popu-
lation sampling, follow-up period, measurements and 
outcomes of interest. Independently, reviewer 1 and 2 
(MY and TG) will subjectively determine the presence 
of these elements; potential answers for the questions 
include yes, no or other (cannot determine, not appli-
cable or not reported). If there is no consensus between 
the two reviewers, then a third reviewer (FF) will resolve 
discrepancies through a discussion. The summary 
of each study will be calculated and expressed as a 
percentage. The interpretation for the scale will be cate-
gorised into four groups: poor (0%–25%), fair (25%–
50%), good (50%–75%) or excellent (75%–100%).
Data items
There will be four categories of extracted data, this 
includes data on citation, study, methods and results 
(see box 1 for extraction list and coding system). In 
the citation category, data on title, lead author, year of 
publication and journal will be extracted. For the study 
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box 1 Extraction list and coding system
1. Citation
a. Title of article
b. Lead author
c. Year published
d. Journal
2. Study
a. Aims/goals/objectives
3. Methods
a. Country of study
b. Study design
c. Study period
d. Sample size
e. Case definition
4. Results
a. Participation rate
b. Demographics of included cohort
c. Total number of non-fatal road traffic collisions (by subgroups)
d. Prevalence, incidence and disease patterns of musculoskeletal 
disorders
section, study aims or goals will be extracted. For the 
methods section, country of study, study design, study 
period, sample size and case definition will be extracted. 
Data extraction in the results section involves extracting 
data related to the reported RTC, this involves partici-
pation rate, demographics of the included cohort and 
total number of non-fatal RTC (per vehicle, per road 
users and per demographics). Additionally, data on 
prevalence, incidence and disease pattern of MSD will 
be extracted, and if available, data on the determinants 
of RTC will also be extracted. Data will be grouped by 
country of study, year, age, sex, type of MSD and type of 
RTC determinant. We define prevalence as the propor-
tion of individuals in a population who have non-fatal 
RTC-related MSD in a specific time period, while 
incidence rate is the number of new cases who have 
non-fatal RTC-related MSD during a certain period of 
time.14
Analysis
Extracted data will be analysed using a narrative 
synthesis. Findings will be presented in tables, with the 
main outcomes being prevalence, incidence and disease 
pattern of MSD. Further, data will be grouped by country 
of study, year, age, sex and type of MSD.
Ethics and dissemination
As individual patients will not be involved in this study, 
no ethical approval will be sought. Findings from this 
review will be disseminated through peer-reviewed jour-
nals and relevant conferences.
Patient and public involvement
There was no patient or public involvement in any 
phase of this study, this included the development of 
the research question, the analysis and the conclusions.
dISCuSSIon
This systematic review will provide a synthesis of the 
current evidence pertaining to the prevalence and inci-
dence of non-fatal RTC in Africa. Conclusion drawn from 
this is envisaged to inform future policies and public 
health prevention strategies to minimise the burden 
related to RTC in Africa. This review has some limitations. 
First, it is likely that there will be some under-reporting in 
the incidence of RTC within Africa.8 Second, it is likely 
that studies will be heterogeneous in quality and design.
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